Search

Author/Creator Haas, Naomi

1. A phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumours. Issue 10 (13th November 2018)

Authors:
Maity, Amit; Mick, Rosemarie; Huang, Alexander; George, Sangeeth; Farwell, Michael; Lukens, John; Berman, Abigail; Mitchell, Tara; Bauml, Josh; Schuchter, Lynn; O'Hara, Mark; Lin, Lilie; Demichele, Angela; Christodouleas, John; Haas, Naomi; Patsch, Dana; Hahn, Stephen; Minn, Andy; Wherry, E.; Von...
Journal:
British journal of cancer
Issue:
Volume 119:Issue 10(2018)
Page Start:
1200
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study. Issue 4 (April 2019)

Authors:
Martínez Chanzá, Nieves; Xie, Wanling; Asim Bilen, Mehmet; Dzimitrowicz, Hannah; Burkart, Jarred; Geynisman, Daniel M; Balakrishnan, Archana; Bowman, I Alex; Jain, Rohit; Stadler, Walter; Zakharia, Yousef; Narayan, Vivek; Beuselinck, Benoit; McKay, Rana R; Tripathi, Abhishek; Pachynski, Russell; ...
Journal:
Lancet oncology
Issue:
Volume 20:Issue 4(2019)
Page Start:
581
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Phase I-II study of ADXS31-142 alone and in combination with pembrolizumab in patients with previously treated metastatic castration-resistant prostate cancer (mCRPC): the KEYNOTE-046 trial. Issue 2 (December 2015)

Authors:
Haas, Naomi; Stein, Mark; Tutrone, Ronald; Perini, Rodolfo; Denker, Andrew; Mauro, David; Fong, Lawrence
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3:Issue 2(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗